We use cookies for a better user experience. Read our Privacy Policy

I Agree

Contract Research Organization (CRO) Services Market

Contract Research Organization (CRO) Services Market (Service Type: Early Phase Development [Discovery Services, Chemistry, and Preclinical Services], Clinical Research Services [Phase I, Phase II, Phase III, and Phase IV], Laboratory Services [Bioanalytical Services, Analytical Services, and Others], and Consulting Services; Therapeutic Indication: Oncology, Infectious Diseases, Immunological Disorders, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, and Others; and End User: Medical Device Companies, Biopharmaceutical Companies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Rise in Number of Drug Development Projects to Propel Demand for CRO Services

CRO services have gradually penetrated the healthcare sector in the past few years. With significant developments in the healthcare sector in terms of research, medications, drug delivery, etc., CROs are increasingly gaining prominence. As healthcare providers continue to recognize the benefits and advantages of consulting and opting for CRO services, the demand for such services is expected to grow at a significant pace during the forecast period (2019-2027). In the past few years, instead of outsourcing the entire project, biotech companies are leaning toward outsourcing part of clinical trials to CROs. In addition, stakeholders in the current contract research organization (CRO) services market are focusing their attention toward catering to niche and customized requirements of clinical trials.

In recent times, CRO services are assisting companies in the early phase development of new drugs and medications. Clinical research, consulting, and laboratory CRO services are increasingly being used by pharmaceutical companies, a factor expected to propel the growth of the contract research organization (CRO) services market during the assessment period. In addition, stakeholders involved in the current contract research organization (CRO) services market are expected to collaborate with each other to formulate open technology standards that are likely to revolutionize the future of clinical trial operations. Due to these factors and positive outlook of the healthcare sector, the global contract research organization (CRO) services market is expected to reach a value of ~US$ 96.4 Bn by 2027.

contract research organizations services market infographic

To know the scope of our report Get a Sample on Contract Research Organization (CRO) Services Market   

Focus on R&D in Pharmaceuticals Offers Growth Opportunities for Stakeholders

In the past decade, research and development in the pharmaceutical sector has experienced considerable increase. Established companies in the pharmaceutical sector are leaning toward leaner business models wherein dependence on external entities, such as CROs, is high. The significant growth of the biotech sector in the past decade has played an important role in resulting in rise in the number of companies involved in research and drug development. The exponential rise in the number of active and upcoming drug development companies and research projects created a huge window of opportunity for stakeholders involved in the contract research organization (CRO) services market. In the past decade, outsourcing of large or complex aspects of the drug development process has become imperative for the development of new drugs effectively and cost-effectively.

Get a glimpse of the in-depth analysis through our Report Brochure

Although drug developers are increasingly leveraging CROs services, they are continually seeking solutions to address a host of challenges involved with this approach, such as high R&D cost, obtaining access and tracking the operations that are outsourced, and capacity constraints, among others. At present, stakeholders in the contract research organization (CRO) services market are increasingly adapting to the evolving research & development requirements and are expected to manage contracted work in several modalities. The number of outsourced projects in the last decade has transformed the overall structure of the drug development industry.

Adoption of CROs Services to Accelerate Early Phase Drug Development

The lack of horizontal integration in the contract research organization (CRO) services market has largely been responsible for the inefficiencies in the operations and workflows. Furthermore, this has also isolated drug development processes, which has thus, encouraged the formulation of integrated CRO services models. The growing adoption of integrated model across the pharmaceutical sector has played an integral role in improving efficiency and minimizing the make-test cycle. While the horizontal integration model offered significant benefits and efficiencies in the drug development phase, its adoption in the U.S. was relatively slower than European countries such as the U.K. The demand for CROs services for early phase drug development and clinical research is expected to grow in the coming decade, due to a range of factors, including improved efficiency, streamlined management of R&D costs, low risk of repeat studies, accelerated drug development, and lowered operational costs, among others. Apart from offering monetary benefits, integrated contract organization services are likely to simply the supply chain and efficient management of clinical data.

contract research organizations services market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global contract research organization (CRO) services market is expected to grow at an impressive CAGR of ~8% during the forecast period. The growth of the market can be largely attributed to significant rise in the number of drug development projects across the globe. Moreover, biotech and pharmaceutical companies are increasingly relying on CRO services to complete certain steps of the clinical development of drugs, which will create significant demand for CRO services during the forecast period. The outlook for the contract research organization (CRO) services market during the forecast period is positive, owing to the advent of integrated CRO models. Additionally, Stakeholders in the contract research organization (CRO) services market should focus on collaborating with pharmaceutical companies and leverage opportunities in North America and Europe– the two prominent regions in which large-scale drug development projects are being initiated.

Contract Research Organization (CRO) Services Market: Overview

  • The global contract research organization (CRO) Services market was valued at ~US$ 49 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027. The global market is driven by increased spending on research and development by manufacturers, patent expiries of various biologics leading to increase in the number of clinical trials, rising penetration of CROs, and growing focus of market players on conducting clinical trials in emerging markets.
  • Contract research organizations (CROs) are engaged in offering a range of research services on a contract basis to pharmaceutical, medical device, and biotechnology companies
  • Large biopharmaceutical companies have been outsourcing most of their research and development activities in order to shift from fixed costs to variable costs, increase their access to new technological capabilities, and expand their global reach. This is promoting growth of the global contract research organization (CRO) services market.
  • Rising prevalence of cancer globally is a key factor driving the number of clinical trials being conducted. Furthermore, the global number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. 

Contract Research Organization (CRO) Services: Market Segmentation

  • The global contract research organization (CRO) services market has been segmented based on service type, therapeutic indication, end user, and region
  • In terms of service type, the global contract research organization (CRO) services market has been categorized into early phase development, clinical research services, laboratory services, and consulting services. The early phase development segment has been sub-segmented into discovery services, chemistry, and preclinical services. The preclinical services sub-segment has been further divided into toxicology, pharmacokinetics, and others. The clinical research services segment has been sub-classified into phase I, phase II, phase III, and phase IV. The laboratory services segment has been sub-categorized into bioanalytical services, analytical services, and others.
  • Based on therapeutic indication, the global contract research organization (CRO) services market has been segregated into oncology, infectious diseases, immunological diseases, respiratory diseases, cardiovascular diseases, neurological disorders, and others
  • Based on end user, the global contract research organization (CRO) services market has been divided into medical device companies, biopharmaceutical companies, and others 

Contract Research Organization (CRO) Services Market: Regional Segmentation

  • In terms of region, the global contract research organization (CRO) services market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global contract research organization (CRO) services market in 2018 and the trend is expected to continue throughout the forecast period
  • The contract research organization (CRO) services market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. Japan is one of the largest industries for clinical trials in Asia Pacific and it witnesses significant product registrations. Large-sized CROs operating worldwide are focused on expanding their presence in Japan through investments in facilities and resources in functional services such as central laboratories, imaging, and clinical supplies. 

Contract Research Organization (CRO) Services Market: Major Players

  • Key players operating in the global contract research organization (CRO) services market are
    • Laboratory Corporation of America Holdings
    • IQVIA Inc.
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences, Inc.
    • PPD, Inc.
    • Charles River Laboratories, Inc.
    • Icon plc
    • WuXi AppTec Group
    • Medpace
  • These players are focused on adopting inorganic growth strategies to strengthen their product portfolio. These companies have adopted strategies such as partnerships and acquisitions to strengthen their market position, expand their portfolio of services, and expand their geographical presence. 

Contract Research Organization (CRO) Services Market – Segmentation

Service Type

Early Phase Development

  • Discovery Services
  • Chemistry
  • Preclinical Services
    • Toxicology
    • Pharmacokinetics
    • Others

Clinical Research Services

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Laboratory Services

  • Bioanalytical Services
  • Analytical Services
  • Others

Consulting Services

Therapeutic Indication

Oncology

Infectious Diseases

Immunological Disorders

Respiratory Diseases

Cardiovascular Diseases

Neurological Disorders

Others

End User

Medical Device Companies

Biopharmaceutical Companies

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Contract Research Organization (CRO) Services Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of contract research organization (CRO) services market?

Contract research organization (CRO) services market is expected to reach a value of ~US$ 96.4 Bn by 2027

What is the anticipated CAGR of the contract research organization (CRO) services market in the forecast period?

Contract research organization (CRO) services market is projected to expand at a high CAGR of 8% during 2019 - 2027

What are the key driving factors for the growth of the contract research organization (CRO) services market?

Contract research organization (CRO) services market is driven by increase in the penetration of CROs, globalization of clinical trials

Which region is expected to project the highest market share in the global contract research organization (CRO) services market?

North America accounted for a major share of the global contract research organization (CRO) services market and the trend is anticipated to continue during the forecast period

Who are the key players in the global contract research organization (CRO) services market?

Key players operating in the global contract research organization (CRO) services market are Laboratory Corporation of America Holdings, IQVIA Inc., Syneos Health, Inc., Parexel International Corporation, PRA Health Sciences

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary: Global Contract Research Organization (CRO) Services Market

5. Market Overview

    5.1. Definition

    5.2. Market Indicators

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunities

6. Market Outlook

    6.1. Global Contract Research Organization (CRO) Services Market Revenue (US$ Mn) Forecast 2017–2027

    6.2. Global Contract Research Organization (CRO) Services Market Outlook

    6.3. Regulatory Scenario, by Region/Global

    6.4. Clinical Trials Analysis

    6.5. Key Mergers and Acquisitions

    6.6. Heat Map Analysis

    6.7. CROs - Business Model

    6.8. CROs - Pricing Strategies

7. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Service Type 

    7.1. Introduction 

    7.2. Global CRO Services Market Value Share Analysis, by Service Type

    7.3. Global CRO Services Market Value Forecast, by Service Type, 2017–2027

        7.3.1. Early Phase Development 

            7.3.1.1. Discovery Services

            7.3.1.2. Chemistry

            7.3.1.3. Preclinical Services 

                7.3.1.3.1. Toxicology

                7.3.1.3.2. Pharmacokinetics 

                7.3.1.3.3. Others

        7.3.2. Clinical Research Services

            7.3.2.1. Phase I

            7.3.2.2. Phase II

            7.3.2.3. Phase III

            7.3.2.4. Phase IV

        7.3.3. Laboratory Services 

            7.3.3.1. Bioanalytical Services 

            7.3.3.2. Analytical Services 

            7.3.3.3. Others

        7.3.4. Consulting Services 

    7.4. Global CRO Services Market Attractiveness, by Service Type 

8. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Therapeutic Indication 

    8.1. Introduction 

    8.2. Global CRO Services Market Value Share Analysis, by Therapeutic Indication

    8.3. Global CRO Services Market Value Forecast, by Therapeutic Indication, 2017–2027

        8.3.1. Oncology

        8.3.2. Infectious Diseases

        8.3.3. Immunological Disorders

        8.3.4. Respiratory Diseases

        8.3.5. Cardiovascular Diseases

        8.3.6. Neurological Disorders

        8.3.7. Others

    8.4. Global CRO Services Market Attractiveness, by Therapeutic Indication

9. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by End-user 

    9.1. Introduction 

    9.2. Global CRO Services Market Value Share Analysis, by End-user

    9.3. Global CRO Services Market Value Forecast, by End-user, 2017–2027

        9.3.1. Medical Device Companies 

        9.3.2. Biopharmaceutical Companies 

        9.3.3. Others

    9.4.  Global CRO Services Market Attractiveness, by End-user

10. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Region 

    10.1. Regional Outlook

    10.2. Global Scenario

    10.3. Introduction

    10.4. Global Contract Research Organization (CRO) Services Market Value Forecast, by Region

        10.4.1. North America

        10.4.2. Europe 

        10.4.3. Asia Pacific

        10.4.4. Latin America 

        10.4.5. Middle East & Africa

    10.5. Global CRO Services Market Attractiveness, by Region

11. North America Contract Research Organization (CRO) Services Market Analysis and Forecast

    11.1.  Key Findings

    11.2.  North America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

        11.2.1. Early Phase Development 

            11.2.1.1. Discovery Services

            11.2.1.2. Chemistry

            11.2.1.3. Preclinical Services 

                11.2.1.3.1. Toxicology

                11.2.1.3.2. Pharmacokinetics 

                11.2.1.3.3. Others

        11.2.2. Clinical Research Services

            11.2.2.1. Phase I

            11.2.2.2. Phase II

            11.2.2.3. Phase III

            11.2.2.4. Phase IV

        11.2.3. Laboratory Services 

            11.2.3.1. Bioanalytical Services 

            11.2.3.2. Analytical Services 

            11.2.3.3. Others

        11.2.4. Consulting Services 

    11.3. North America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

        11.3.1. Oncology

        11.3.2. Infectious Diseases

        11.3.3. Immunological Disorders

        11.3.4. Respiratory Diseases

        11.3.5. Cardiovascular Diseases

        11.3.6. Neurological Disorders

        11.3.7. Others

    11.4. North America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

        11.4.1. Medical Device Companies 

        11.4.2. Biopharmaceutical Companies 

        11.4.3. Others

    11.5. North America Contract Research Organization (CRO) Services Market Value Forecast, by Country, 2017–2027

        11.5.1. U.S.

        11.5.2. Canada

    11.6. North America Contract Research Organization (CRO) Services Market Attractiveness Analysis

        11.6.1. By Service Type

        11.6.2. By Therapeutic Indication

        11.6.3. By End-user

        11.6.4. By Country

12. Europe Contract Research Organization (CRO) Services Market Analysis and Forecast

    12.1.  Key Findings

    12.2.  Europe Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

        12.2.1. Early Phase Development 

            12.2.1.1. Discovery Services

            12.2.1.2. Chemistry

            12.2.1.3. Preclinical Services 

                12.2.1.3.1. Toxicology

                12.2.1.3.2. Pharmacokinetics 

                12.2.1.3.3. Others

        12.2.2. Clinical Research Services

            12.2.2.1. Phase I

            12.2.2.2. Phase II

            12.2.2.3. Phase III

            12.2.2.4. Phase IV

        12.2.3. Laboratory Services 

            12.2.3.1. Bioanalytical Services 

            12.2.3.2. Analytical Services 

            12.2.3.3. Others

        12.2.4. Consulting Services 

    12.3. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

        12.3.1. Oncology

        12.3.2. Infectious Diseases

        12.3.3. Immunological Disorders

        12.3.4. Respiratory Diseases

        12.3.5. Cardiovascular Diseases

        12.3.6. Neurological Disorders

        12.3.7. Others

    12.4. Europe Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

        12.4.1. Medical Device Companies 

        12.4.2. Biopharmaceutical Companies 

        12.4.3. Others

    12.5. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. U.K.

        12.5.2. Germany

        12.5.3. France

        12.5.4. Italy 

        12.5.5. Spain

        12.5.6. Rest of Europe

    12.6. Europe Contract Research Organization (CRO) Services Market Attractiveness Analysis

        12.6.1. By Service Type

        12.6.2. By Therapeutic Indication

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Asia Pacific Contract Research Organization (CRO) Services Market Analysis and Forecast

    13.1.  Key Findings

    13.2.  Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

        13.2.1. Early Phase Development 

            13.2.1.1. Discovery Services

            13.2.1.2. Chemistry

            13.2.1.3. Preclinical Services 

                13.2.1.3.1. Toxicology

                13.2.1.3.2. Pharmacokinetics 

                13.2.1.3.3. Others

        13.2.2. Clinical Research Services

            13.2.2.1. Phase I

            13.2.2.2. Phase II

            13.2.2.3. Phase III

            13.2.2.4. Phase IV

        13.2.3. Laboratory Services 

            13.2.3.1. Bioanalytical Services 

            13.2.3.2. Analytical Services 

            13.2.3.3. Others

        13.2.4. Consulting Services 

    13.3. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

        13.3.1. Oncology

        13.3.2. Infectious Diseases

        13.3.3. Immunological Disorders

        13.3.4. Respiratory Diseases

        13.3.5. Cardiovascular Diseases

        13.3.6. Neurological Disorders

        13.3.7. Others

    13.4. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

        13.4.1. Medical Device Companies 

        13.4.2. Biopharmaceutical Companies 

        13.4.3. Others

    13.5. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. China

        13.5.2. India

        13.5.3. Japan

        13.5.4. Australia & New Zealand 

        13.5.5. Rest of Asia Pacific 

    13.6. Asia Pacific Contract Research Organization (CRO) Services Market Attractiveness Analysis

        13.6.1. By Service Type

        13.6.2. By Therapeutic Indication

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Latin America Contract Research Organization (CRO) Services Market Analysis and Forecast

    14.1.  Key Findings

    14.2.  Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

        14.2.1. Early Phase Development 

            14.2.1.1. Discovery Services

            14.2.1.2. Chemistry

            14.2.1.3. Preclinical Services 

                14.2.1.3.1. Toxicology

                14.2.1.3.2. Pharmacokinetics 

                14.2.1.3.3. Others

        14.2.2. Clinical Research Services

            14.2.2.1. Phase I

            14.2.2.2. Phase II

            14.2.2.3. Phase III

            14.2.2.4. Phase IV

        14.2.3. Laboratory Services 

            14.2.3.1. Bioanalytical Services 

            14.2.3.2. Analytical Services 

            14.2.3.3. Others

        14.2.4. Consulting Services 

    14.3. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

        14.3.1. Oncology

        14.3.2. Infectious Diseases

        14.3.3. Immunological Disorders

        14.3.4. Respiratory Diseases

        14.3.5. Cardiovascular Diseases

        14.3.6. Neurological Disorders

        14.3.7. Others

    14.4. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

        14.4.1. Medical Device Companies 

        14.4.2. Biopharmaceutical Companies 

        14.4.3. Others

    14.5. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

        14.5.1. Brazil

        14.5.2. Mexico

        14.5.3. Rest of Latin America 

    14.6. Latin America Contract Research Organization (CRO) Services Market Attractiveness Analysis

        14.6.1. By Service

        14.6.2. By Therapeutic Indication

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Middle East & Africa Contract Research Organization (CRO) Services Market Analysis and Forecast

    15.1.  Key Findings

    15.2.  Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

        15.2.1. Early Phase Development 

            15.2.1.1. Discovery Services

            15.2.1.2. Chemistry

            15.2.1.3. Preclinical Services 

                15.2.1.3.1. Toxicology

                15.2.1.3.2. Pharmacokinetics 

                15.2.1.3.3. Others

        15.2.2. Clinical Research Services

            15.2.2.1. Phase I

            15.2.2.2. Phase II

            15.2.2.3. Phase III

            15.2.2.4. Phase IV

        15.2.3. Laboratory Services 

            15.2.3.1. Bioanalytical Services 

            15.2.3.2. Analytical Services 

            15.2.3.3. Others

        15.2.4. Consulting Services 

    15.3. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

        15.3.1. Oncology

        15.3.2. Infectious Diseases

        15.3.3. Immunological Disorders

        15.3.4. Respiratory Diseases

        15.3.5. Cardiovascular Diseases

        15.3.6. Neurological Disorders

        15.3.7. Others

    15.4. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

        15.4.1. Medical Device Companies 

        15.4.2. Biopharmaceutical Companies 

        15.4.3. Others

    15.5. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

        15.5.1. GCC 

        15.5.2. South Africa

        15.5.3. Rest of Middle East & Africa 

    15.6. Middle East & Africa Contract Research Organization (CRO) Services Market Attractiveness Analysis

        15.6.1. By Service

        15.6.2. By Therapeutic Indication

        15.6.3. By End-user

        15.6.4. By Country/Sub-region

16. Competition Landscape

    16.1.  Competition Matrix 

    16.2. Global CRO Services Market Share Analysis, by Company, 2018

    16.3.  Company Profiles

        16.3.1. Laboratory Corporation of America Holdings  

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Financial Overview

            16.3.1.3. Product Portfolio

            16.3.1.4. Strategic Overview

            16.3.1.5. SWOT Analysis

        16.3.2. IQVIA Inc. 

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Financial Overview

            16.3.2.3. Product Portfolio

            16.3.2.4. Strategic Overview

            16.3.2.5. SWOT Analysis

        16.3.3. Syneos Health, Inc.

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Financial Overview

            16.3.3.3. Product Portfolio

            16.3.3.4. Strategic Overview

            16.3.3.5. SWOT Analysis

        16.3.4. Parexel International Corporation

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Financial Overview

            16.3.4.3. Product Portfolio

            16.3.4.4. Strategic Overview

            16.3.4.5. SWOT Analysis

        16.3.5. PRA Health Sciences, Inc.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Financial Overview

            16.3.5.3. Product Portfolio

            16.3.5.4. Strategic Overview

            16.3.5.5. SWOT Analysis

        16.3.6. PPD, Inc.

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Financial Overview

            16.3.6.3. Product Portfolio

            16.3.6.4. Strategic Overview

            16.3.6.5. SWOT Analysis

        16.3.7. Charles River Laboratories, Inc.

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Financial Overview

            16.3.7.3. Product Portfolio

            16.3.7.4. Strategic Overview

            16.3.7.5. SWOT Analysis

        16.3.8. Icon plc

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Financial Overview

            16.3.8.3. Product Portfolio

            16.3.8.4. Strategic Overview

            16.3.8.5. SWOT Analysis

        16.3.9. WuXi AppTec Group

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Financial Overview

            16.3.9.3. Product Portfolio

            16.3.9.4. Strategic Overview

            16.3.9.5. SWOT Analysis

        16.3.10. Medpace

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Financial Overview

            16.3.10.3. Product Portfolio

            16.3.10.4. Strategic Overview

            16.3.10.5. SWOT Analysis

List of Tables

Table 01: CROs - Heat Map Analysis

Table 02: CROs – Business Models

Table 03: Global CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 04: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 05: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 06: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 07: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 08: Global CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 09: Global CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 10: Global CRO Services Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 11: North America CRO Services Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 12: North America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 13: North America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 14: North America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 15: North America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 16: North America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 17: North America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 18: North America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 19: Europe CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Europe CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 21: Europe CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 22: Europe CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 23: Europe CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 24: Europe CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 25: Europe CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 26: Europe CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 27: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 28: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 29: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 30: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 31: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 32: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 33: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 34: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 35: Latin America CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 36: Latin America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 37: Latin America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 38: Latin America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 39: Latin America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 40: Latin America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 41: Latin America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 42: Latin America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 43: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 44: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 45: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 46: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 47: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 48: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 49: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 50: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Contract Research Organization (CRO) Services Market Snapshot

Figure 02: Global Contract Research Organization (CRO) Services Market Value (US$ Mn), by Region, 2019 and 2027

Figure 03: Penetration of Clinical CRO Outsourcing Services

Figure 04: Increase in Clinical Trials

Figure 05: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 06: Global CRO Services Market Value Share (%), by Service Type (2019)

Figure 07: Global CRO Services Market Value Share (%), by Therapeutic Indication (2019)

Figure 08: Global CRO Services Market Value Share (%), by End-user (2019)

Figure 09: Global CRO Services Market Value Share (%), by Region (2019)

Figure 10: Regulatory Scenario – North America

Figure 11: Regulatory Scenario – Europe

Figure 12: Regulatory Scenario – Asia Pacific 

Figure 13: Number of Registered Studies, by Location

Figure 14: Number of Registered Studies, by Intervention

Figure 15: Global CRO Services Market – Key Mergers and Acquisitions

Figure 16: CROs- Pricing Strategies 

Figure 17: Key Strategies – Laboratory Corporation of America Holdings (LabCorp) 

Figure 18: Key Strategies – IQVIA 

Figure 19: Global CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 20: Global CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 21: Global CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 22: Global CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 23: Global CRO Services Market Value Share Analysis, by Preclinical Services, 2018 and 2027

Figure 24: Global CRO Services Market Attractiveness, by Preclinical Services, 2019?2027

Figure 25: Global CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 26: Global CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 27: Global CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 28: Global CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 29: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Figure 30: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Figure 31: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Figure 32: Global CRO Services Market Value (US$ Mn) Forecast, by Consulting Services, 2017–2027

Figure 33: Global CRO Services Market Value (US$ Mn) Forecast, by Discovery Services, 2017–2027

Figure 34: Global CRO Services Market Value (US$ Mn) Forecast, by Chemistry, 2017–2027

Figure 35: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Figure 36: Global CRO Services Market Value (US$ Mn) Forecast, by Phase I, 2017–2027

Figure 37: Global CRO Services Market Value (US$ Mn) Forecast, by Phase II, 2017–2027

Figure 38: Global CRO Services Market Value (US$ Mn) Forecast, by Phase III, 2017–2027

Figure 39: Global CRO Services Market Value (US$ Mn) Forecast, by Phase IV, 2017–2027

Figure 40: Global CRO Services Market Value (US$ Mn) Forecast, by Bio-analytical services, 2017–2027

Figure 41: Global CRO Services Market Value (US$ Mn) Forecast, by Analytical Services, 2017–2027

Figure 42: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 43: Global CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 44: Global CRO Services Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Figure 45: Global CRO Services Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2027

Figure 46: Global CRO Services Market Value (US$ Mn) Forecast, by Immunological Disorders, 2017–2027

Figure 47: Global CRO Services Market Value (US$ Mn) Forecast, by Respiratory Diseases, 2017–2027

Figure 48: Global CRO Services Market Value (US$ Mn) Forecast, by Cardiovascular Diseases, 2017–2027

Figure 49: Global CRO Services Market Value (US$ Mn) Forecast, by Neurological Disorders, 2017–2027

Figure 50: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 51: Global CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 52: Global CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 53: Global CRO Services Market Value (US$ Mn) Forecast, by Medical Device Companies , 2017–2027

Figure 54: Global CRO Services Market Value (US$ Mn) Forecast, by Biopharmaceutical Companies, 2017–2027

Figure 55: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 56: Global CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 57: Global CRO Services Market: Regional Outlook

Figure 58: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 59: Global CRO Services Market Value Share Analysis, by Region, 2018 and 2027

Figure 60: Global CRO Services Market Attractiveness, by Region, 2019?2027

Figure 61: North America CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 62: North America CRO Services Market Attractiveness Analysis, by Country, 2019–2027

Figure 63: North America CRO Services Market Value Share Analysis, by Country, 2018 and 2027

Figure 64: North America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 65: North America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 66: North America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 67: North America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 68: North America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 69: North America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 70: North America CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 71: North America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 72: North America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 73: North America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 74: North America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 75: North America CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 76: Europe CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 77: Europe CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 78: Europe CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 79: Europe CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 80: Europe CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 81: Europe CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 82: Europe CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 83: Europe CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 84: Europe CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 85: Europe CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 86: Europe CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 87: Europe CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 88: Europe CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 89: Europe CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 90: Europe CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 91: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 92: Asia Pacific CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 93: Asia Pacific CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 94: Asia Pacific CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 95: Asia Pacific CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 96: Asia Pacific CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 97: Asia Pacific CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 98: Asia Pacific CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 99: Asia Pacific CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 100: Asia Pacific CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 101: Asia Pacific CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 102: Asia Pacific CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 103: Asia Pacific CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 104: Asia Pacific CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 105: Asia Pacific CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 106: Latin America CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 107: Latin America CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 108: Latin America CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 109: Latin America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 110: Latin America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 111: Latin America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 112: Latin America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 113: Latin America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 114: Latin America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 115: Latin America CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 116: Latin America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 117: Latin America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 118: Latin America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 119: Latin America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 120: Latin America CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 121: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 122: Middle East & Africa CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 123: Middle East & Africa CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 124: Middle East & Africa CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 125: Middle East & Africa CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 126: Middle East & Africa CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 127: Middle East & Africa CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 128: Middle East & Africa CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 129: Middle East & Africa CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 130: Middle East & Africa CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 131: Middle East & Africa CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 132: Middle East & Africa CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 133: Middle East & Africa CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 134: Middle East & Africa CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 135: Middle East & Africa CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 136: Global CRO Services Market Share, by Company, 2018

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

322

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved